Norges Bank’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Norges Bank’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-513,519	Closed	-$88.7M	–	2362
2015 Q1	$88.7M	Buy	513,519 +21,772	+4%	+$3.2M	0.04%	420
2014 Q4	$56.5M	Buy	491,747 +64,245	+15%	+$7.78M	0.03%	582
2014 Q3	$66.8M	Sell	427,502 -352,624	-45%	-$51.1M	0.04%	482
2014 Q2	$96.2M	Buy	780,126 +390,063	+100%	+$43.1M	0.03%	639
2014 Q1	$40.4M	Hold	390,063	–	–	0.02%	694
2013 Q4	$35.1M	Buy	390,063 +23,518	+6%	+$1.88M	0.02%	763
2013 Q3	$24.5M	Buy	366,545 +89,313	+32%	+$6.15M	0.01%	945
2013 Q2	$18.3M	Buy	+277,232	New	+$15.9M	0.01%	1074

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Norges Bank's SLXP Position: Q2 2015 in Review

Norges Bank sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 513,519 shares — an estimated $88.7M sold.

Norges Bank first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $96.2M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Norges Bank reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Norges Bank sold 513,519 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $88.7M.
Norges Bank first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Norges Bank's SALIX PHARMACEUTICALS LTD DEL position peaked at $96.2M in Q2 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Norges Bank's 13F filing for Q2 2015, filed 10 Aug 2015.